Xue-si Wu

628 total citations
28 papers, 472 citations indexed

About

Xue-si Wu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xue-si Wu has authored 28 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xue-si Wu's work include Cardiovascular Function and Risk Factors (4 papers), Coronary Interventions and Diagnostics (4 papers) and Acute Myocardial Infarction Research (4 papers). Xue-si Wu is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Coronary Interventions and Diagnostics (4 papers) and Acute Myocardial Infarction Research (4 papers). Xue-si Wu collaborates with scholars based in China, United States and Myanmar. Xue-si Wu's co-authors include Yabei Xu, Jian Zhang, Runlin Gao, Xinchun Yang, Xinyan Li, Xifu Liu, Tianchang Li, Dong Wei, Mingdong Zhou and Xiaoxia Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, IEEE Transactions on Medical Imaging and Medicine.

In The Last Decade

Xue-si Wu

26 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue-si Wu China 10 242 169 140 82 76 28 472
Megan V. Cannon Netherlands 10 177 0.7× 206 1.2× 188 1.3× 40 0.5× 79 1.0× 12 526
Fatiha Maskali France 13 128 0.5× 188 1.1× 120 0.9× 36 0.4× 97 1.3× 30 557
Nili Naftali‐Shani Israel 14 288 1.2× 292 1.7× 170 1.2× 82 1.0× 38 0.5× 23 711
Sanne de Jong Netherlands 10 523 2.2× 249 1.5× 107 0.8× 44 0.5× 90 1.2× 21 769
Myrielle Mathieu Belgium 12 156 0.6× 177 1.0× 171 1.2× 125 1.5× 32 0.4× 24 556
Wolfgang Boecker Germany 9 183 0.8× 143 0.8× 78 0.6× 113 1.4× 32 0.4× 20 409
Tomoaki Higo Japan 12 253 1.0× 356 2.1× 195 1.4× 47 0.6× 57 0.8× 21 678
Eef Dries Belgium 14 449 1.9× 323 1.9× 131 0.9× 57 0.7× 37 0.5× 25 662
Changqing Du China 13 137 0.6× 231 1.4× 90 0.6× 34 0.4× 39 0.5× 36 466
Miikka Tarkia Finland 13 126 0.5× 128 0.8× 133 0.9× 40 0.5× 115 1.5× 27 429

Countries citing papers authored by Xue-si Wu

Since Specialization
Citations

This map shows the geographic impact of Xue-si Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue-si Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue-si Wu more than expected).

Fields of papers citing papers by Xue-si Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue-si Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue-si Wu. The network helps show where Xue-si Wu may publish in the future.

Co-authorship network of co-authors of Xue-si Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue-si Wu. A scholar is included among the top collaborators of Xue-si Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue-si Wu. Xue-si Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Xiaoxia, et al.. (2012). Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/Akt and inhibiting mitochondrial permeability transition pore. Molecular and Cellular Biochemistry. 370(1-2). 35–43. 38 indexed citations
3.
Gao, Runlin, Jian Zhang, Xue-si Wu, et al.. (2010). A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 55(18). 1907–1914. 212 indexed citations
4.
Liu, Xiaohui, Shaoping Nie, Qiang Lü, et al.. (2010). Prognostic value of baseline C-reactive protein levels in patients undergoing coronary revascularization. Chinese Medical Journal. 123(13). 1628–1632. 5 indexed citations
5.
Wu, Xue-si, et al.. (2010). Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.. PubMed. 123(24). 3597–604. 52 indexed citations
6.
Ma, Changsheng, Shaoping Nie, Xiaohui Liu, et al.. (2009). Twelve Months Clinical Outcome of Drug‐Eluting Stents Implantation or Coronary Artery Bypass Surgery for the Treatment of Diabetic Patients with Multivessel Disease. Clinical Cardiology. 32(8). E24–30. 15 indexed citations
7.
Dong, Ran, et al.. (2009). Hypereosinophilia with a giant thrombus in the right ventricle: Löffler endocarditis in an 11-year-old girl.. PubMed. 122(23). 2914–6. 2 indexed citations
8.
Ren, Xuejun, et al.. (2009). [Cardiac manifestations of Fabry's disease].. PubMed. 48(6). 462–4. 1 indexed citations
9.
10.
Liu, Xinmin, et al.. (2008). [Anemia as an independent predictor of poor long-term outcomes after percutaneous coronary intervention].. PubMed. 47(2). 114–6. 1 indexed citations
11.
Wu, Xue-si. (2008). [2007 version of guidelines for chronic heart failure in China].. PubMed. 47(4). 267–8. 2 indexed citations
12.
Yu, Li, et al.. (2008). [The incidence and predictors of atrial fibrillation in hypertrophic cardiomyopathy].. PubMed. 47(6). 475–7. 2 indexed citations
13.
Que, Bin, Changsheng Ma, Shaoping Nie, et al.. (2007). [Impact of chronic anemia on in-hospital clinical outcome of revascularization in patients with coronary artery disease].. PubMed. 19(11). 641–3. 1 indexed citations
14.
Zhang, Qiang, Changsheng Ma, Shaoping Nie, et al.. (2007). Prevalence and Impact of Renal Insufficiency on Clinical Outcomes of Patients Undergoing Coronary Revascularization. Circulation Journal. 71(8). 1299–1304. 11 indexed citations
15.
Wu, Xue-si, et al.. (2006). [Simvastatin inhibits hypertension-induced cardiac hypertrophy in rats through activation of heme oxygenase-1/carbon monoxide pathway].. PubMed. 58(2). 116–23. 3 indexed citations
16.
Nie, Shaoping, Xiaohui Liu, Jun-ping Kang, et al.. (2006). [Profile of risk factors modification after coronary revascularization in patients with coronary artery disease].. PubMed. 86(16). 1097–101. 2 indexed citations
17.
Nie, Shaoping, Yin Zhang, Xin Du, et al.. (2005). [Evaluation of early invasive or initially conservative strategies in patients with non-ST-segment elevation acute coronary syndrome at intermediate or high risk].. PubMed. 33(4). 307–11. 1 indexed citations
18.
Wu, Xue-si, Robert C. Bahn, & Erik L. Ritman. (1995). Myocardial Microcirculation as Evaluated with CT. Advances in experimental medicine and biology. 382. 261–268. 3 indexed citations
19.
Pan, Jianan, et al.. (1991). The Study of Serum Apoprotein Levels as Indicators for the Severity of Angiographically Assessed Coronary Artery Disease. American Journal of Clinical Pathology. 95(4). 597–600. 5 indexed citations
20.
Wang, Tao, Xue-si Wu, Namsik Chung, & Erik L. Ritman. (1989). Myocardial blood flow estimated by synchronous, multislice, high-speed computed tomography. IEEE Transactions on Medical Imaging. 8(1). 70–77. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan V. Cannon Breakdown of academic impact, for papers by Fatiha Maskali Breakdown of academic impact, for papers by Nili Naftali‐Shani Breakdown of academic impact, for papers by Sanne de Jong Breakdown of academic impact, for papers by Myrielle Mathieu Breakdown of academic impact, for papers by Wolfgang Boecker Breakdown of academic impact, for papers by Tomoaki Higo Breakdown of academic impact, for papers by Eef Dries Breakdown of academic impact, for papers by Changqing Du Breakdown of academic impact, for papers by Miikka Tarkia
Rankless by CCL
2026